Skip Navigation



Human Molecular Genetics Advance Access published online on November 23, 2005

Human Molecular Genetics, doi:10.1093/hmg/ddi398
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
15/1/1    most recent
ddi398v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Al-Zahrani, A.
Right arrow Articles by Dunning, A. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Zahrani, A.
Right arrow Articles by Dunning, A. M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved
Received September 1, 2005
Revised October 14, 2005
Accepted October 14, 2005

Article

IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer

Ali Al-Zahrani 1, Manjinder S Sandhu 2, Robert N Luben 3, Deborah Thompson 4, Caroline Baynes 1, Karen A. Pooley 1, Craig Luccarini 1, Hannah Munday 1, Barbara Perkins 1, Paula Smith 4, Paul DP Pharoah 1, Nicholas J Wareham 5, Douglas F Easton 4, Bruce A J Ponder 1, and Alison M Dunning 1 *

1 CR-UK Department of Oncology, Strangeways Research Laboratory, Worts Causeway, Cambridge, CB1 8RN, UK
2 Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, Cambridge, CB1 8RN, UK
3 EPIC, Strangeways Research Laboratory, Worts Causeway, Cambridge, CB1 8RN, UK
4 CR-UK Genetic Epidemiology Unit, Strangeways Research Laboratory, Worts Causeway, Cambridge, CB1 8RN, UK
5 MRC Epidemiology Unit, Strangeways Research Laboratory, Worts Causeway, Cambridge, CB1 8RN, UK

* To whom correspondence should be addressed.
Alison M Dunning, E-mail: alisond{at}srl.cam.ac.uk


   Abstract

Experimental and observational studies in humans and animals suggest that insulin-like growth factor 1 (IGF1) and its principle binding protein, IGFBP3, may influence breast cancer susceptibility. We have examined the association of 9 single nucleotide polymorphisms (SNPs) in the IGF1 gene and 4 in the IGFBP3 gene with circulating levels of their gene products in a population-based study of 600 middle-aged men and women, and in a breast cancer case-control study, comprised of up to 4,647 cases and 4,564 controls. All study participants are from the East Anglian region of England. SNPs were specifically chosen to tag all other known SNPs in each gene. Several SNPs in each gene are associated with both circulating levels of their respective proteins and with risk of breast cancer. In particular, the c allele of IGF1 SNP rs1520220 is associated with increased circulating IGF1 (r2 = 2.1%, P-trend = 0.003) in females and an increased risk of breast cancer: Odds Ratio (OR)(cc/gg)  = 1.41; 95% Confidence Intervals (95%CIs) 1.11-1.79; P-trend = 0.03). The a allele of IGFBP3 SNP rs2854744 is associated with increased circulating IGFBP3 (r2 = 9.7%, P < 10-9) and a decreased risk of breast cancer: OR (aa/cc)  = 0.87; 95%CIs 0.77-0.99; P = 0.03). Our data indicate that common variants in the IGF1 and IGFBP3 genes are associated with differences in circulating levels of IGF1 and IGFBP3 and with breast cancer risk. More specifically and consistent with experimental models, our data suggest that higher IGF1 levels may increase the risk of breast cancer but higher IGFBP3 levels may be protective.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. A. D'Aloisio, J. C. Schroeder, K. E. North, C. Poole, S. L. West, G. S. Travlos, and D. D. Baird
IGF-I and IGFBP-3 Polymorphisms in Relation to Circulating Levels among African American and Caucasian Women
Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 954 - 966.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. F. Costalonga, S. R. Antonini, G. Guerra-Junior, B. B. Mendonca, I. J. P. Arnhold, and A. A. L. Jorge
The -202 A Allele of Insulin-Like Growth Factor Binding Protein-3 (IGFBP3) Promoter Polymorphism Is Associated with Higher IGFBP-3 Serum Levels and Better Growth Response to Growth Hormone Treatment in Patients with Severe Growth Hormone Deficiency
J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 588 - 595.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. Suzuki, Y. Li, X. Dong, M. M. Hassan, J. L. Abbruzzese, and D. Li
Effect of Insulin-Like Growth Factor Gene Polymorphisms Alone or In Interaction with Diabetes on the Risk of Pancreatic Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3467 - 3473.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
S. Lonn, N. Rothman, W. R. Shapiro, H. A. Fine, R. G. Selker, P. M. Black, J. S. Loeffler, A. A. Hutchinson, and P. D. Inskip
Genetic variation in insulin-like growth factors and brain tumor risk
Neuro-oncol, August 1, 2008; 10(4): 553 - 559.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H-L Wong, W-P Koh, N M Probst-Hensch, D Van den Berg, M C Yu, and S A Ingles
Insulin-like growth factor-1 promoter polymorphisms and colorectal cancer: a functional genomics approach
Gut, August 1, 2008; 57(8): 1090 - 1096.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
Y. Mizuno, N. Hattori, S.-i. Kubo, S. Sato, K. Nishioka, T. Hatano, H. Tomiyama, M. Funayama, Y. Machida, and H. Mochizuki
Progress in the pathogenesis and genetics of Parkinson's disease
Phil Trans R Soc B, June 27, 2008; 363(1500): 2215 - 2227.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. Palles, N. Johnson, B. Coupland, C. Taylor, J. Carvajal, J. Holly, I. S. Fentiman, I. dos Santos Silva, A. Ashworth, J. Peto, et al.
Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy
Hum. Mol. Genet., May 15, 2008; 17(10): 1457 - 1464.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Diorio, J. Brisson, S. Berube, and M. Pollak
Genetic Polymorphisms Involved in Insulin-like Growth Factor (IGF) Pathway in Relation to Mammographic Breast Density and IGF Levels
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 880 - 888.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
V. M. Chia, L. C. Sakoda, B. I. Graubard, M. V. Rubertone, S. J. Chanock, R. L. Erickson, and K. A. McGlynn
Risk of Testicular Germ Cell Tumors and Polymorphisms in the Insulin-Like Growth Factor Genes
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 721 - 726.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. L. Deming, Z. Ren, Q. Cai, X.-O. Shu, W. Wen, J.-R. Long, Y.-T. Gao, and W. Zheng
IGF-I and IGF-II Genetic Variation and Breast Cancer Risk in Chinese Women: Results from the Shanghai Breast Cancer Study
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 255 - 257.
[Full Text] [PDF]


Home page
EndocrinologyHome page
J. Paquette, B. Bessette, E. Ledru, and C. Deal
Identification of Upstream Stimulatory Factor Binding Sites in the Human IGFBP3 Promoter and Potential Implication of Adjacent Single-Nucleotide Polymorphisms and Responsiveness to Insulin
Endocrinology, December 1, 2007; 148(12): 6007 - 6018.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. J. Sigurdson, P. Bhatti, M. M. Doody, M. Hauptmann, L. Bowen, S. L. Simon, R. M. Weinstock, M. S. Linet, M. Rosenstein, M. Stovall, et al.
Polymorphisms in Apoptosis- and Proliferation-Related Genes, Ionizing Radiation Exposure, and Risk of Breast Cancer among U.S. Radiologic Technologists
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2000 - 2007.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Cheng, K. DeLellis Henderson, C. A. Haiman, L. N. Kolonel, B. E. Henderson, M. L. Freedman, and L. Le Marchand
Genetic Determinants of Circulating Insulin-Like Growth Factor (IGF)-I, IGF Binding Protein (BP)-1, and IGFBP-3 Levels in a Multiethnic Population
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3660 - 3666.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Stone, L. C. Gurrin, G. B. Byrnes, C. J. Schroen, S. A. Treloar, E. J.D. Padilla, G. S. Dite, M. C. Southey, V. M. Hayes, and J. L. Hopper
Mammographic Density and Candidate Gene Variants: A Twins and Sisters Study
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1479 - 1484.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y.-L. Low, A. M. Dunning, M. Dowsett, E. Folkerd, D. Doody, J. Taylor, A. Bhaniani, R. Luben, K.-T. Khaw, N. J. Wareham, et al.
Phytoestrogen Exposure Is Associated with Circulating Sex Hormone Levels in Postmenopausal Women and Interact with ESR1 and NR1I2 Gene Variants
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 1009 - 1016.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
The Breast Cancer Association Consortium
Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.
J Natl Cancer Inst, October 4, 2006; 98(19): 1382 - 1396.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. Cheng, K. L. Penney, D. O. Stram, L. Le Marchand, E. Giorgi, C. A. Haiman, L. N. Kolonel, M. Pike, J. Hirschhorn, B. E. Henderson, et al.
Haplotype-Based Association Studies of IGFBP1 and IGFBP3 with Prostate and Breast Cancer Risk: The Multiethnic Cohort.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1993 - 1997.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
A. G Renehan, M. Harvie, and A. Howell
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 273 - 278.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.